Cargando…
No Correlations Between the Development of Specific IgA and IgM Antibodies Against Anti-TNF Blocking Agents, Disease Activity and Adverse Side Reactions in Patients with Rheumatoid Arthritis
The use of tumour necrosis factor (TNF) antagonists (infliximab [IFN], etanercept [ETN], adalimumab [ADA]) has changed the course of many rheumatic diseases, including rheumatoid arthritis (RA). However, some questions concerning their safety have emerged since their approval because they can trigge...
Autores principales: | Benucci, Maurizio, Saviola, Gianantonio, Meacci, Francesca, Manfredi, Mariangela, Infantino, Maria, Campi, Paolo, Severino, Maurizio, Iorno, Miriam, Sarzi-Puttini, Piercarlo, Atzeni, Fabiola |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Open
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3793582/ https://www.ncbi.nlm.nih.gov/pubmed/24115967 http://dx.doi.org/10.2174/1874312901307010075 |
Ejemplares similares
-
Cost Effectiveness Analysis of Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis. A Systematic Review Literature
por: Benucci, Maurizio, et al.
Publicado: (2011) -
Factors correlated with improvement of endothelial dysfunction during rituximab therapy in patients with rheumatoid arthritis
por: Benucci, Maurizio, et al.
Publicado: (2013) -
Antidrug antibodies against TNF-blocking agents: correlations between disease activity, hypersensitivity reactions, and different classes of immunoglobulins
por: Benucci, Maurizio, et al.
Publicado: (2015) -
Correlations between immunogenicity, drug levels, and disease activity in an Italian cohort of rheumatoid arthritis patients treated with tocilizumab
por: Benucci, Maurizio, et al.
Publicado: (2016) -
Clinical Comparison of QUANTA Flash dsDNA Chemiluminescent Immunoassay with Four Current Assays for the Detection of Anti-dsDNA Autoantibodies
por: Infantino, Maria, et al.
Publicado: (2015)